Nabla
Total Raised
$114.26MInvestors Count
9Deal Terms
1Funding, Valuation & Revenue
3 Fundings
Nabla has raised $114.26M over 3 rounds.
Nabla's latest funding round was a Series C for $70M on June 17, 2025.
Nabla's valuation in January 2024 was $180M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/17/2025 | Series C | $70M | 4 | |||
1/5/2024 | Series B | $180M | ||||
4/9/2021 | Series A |
Date | 6/17/2025 | 1/5/2024 | 4/9/2021 |
|---|---|---|---|
Round | Series C | Series B | Series A |
Amount | $70M | ||
Investors | |||
Valuation | $180M | ||
Revenue | |||
Sources | 4 |
Nabla Deal Terms
1 Deal Term
Nabla's deal structure is available for 1 funding round, including their Series B from January 05, 2024.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Nabla Investors
9 Investors
Nabla has 9 investors. Cathay Innovation invested in Nabla's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/5/2024 | 6/17/2025 | 2 Series B, Series C (2025) | Venture Capital | California | ||
Venture Capital | Cayman Islands | |||||
Venture Capital | France | |||||
Venture Capital | Germany | |||||
Growth Equity | United Kingdom |
First funding | 1/5/2024 | ||||
|---|---|---|---|---|---|
Last Funding | 6/17/2025 | ||||
Investor | |||||
Rounds | 2 Series B, Series C (2025) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Venture Capital | Growth Equity |
Location | California | Cayman Islands | France | Germany | United Kingdom |
Compare Nabla to Competitors
Abridge focuses on generative artificial intelligence (AI) for clinical conversations within the healthcare sector. The company provides AI solutions that create AI-generated notes intended for use in patient-clinician interactions. It serves healthcare systems, intending to enhance clinician efficiency and nursing documentation. Abridge was formerly known as Intelligible.AI. It was founded in 2018 and is based in Philadelphia, Pennsylvania.
Ambience operates as a healthcare technology company that provides ambient artificial intelligence (AI) solutions for clinical documentation, coding, and patient summaries. The company has a platform that integrates with electronic health records (EHRs) to support patient care, specialty workflows, documentation accuracy, and billing processes. Ambience serves the healthcare sector with tools aimed at addressing clinician burnout. It was founded in 2020 and is based in San Francisco, California.
Heidi Health provides AI-driven healthcare solutions within the medical technology sector. The company offers an AI scribe that assists clinicians by capturing clinical notes, generating summaries, and facilitating follow-ups during patient consults. Heidi Health's products aim to reduce administrative tasks for healthcare professionals. It was founded in 2019 and is based in Cremorne, Australia.
DeepScribe automates medical documentation through its platform in the healthcare sector. It provides a medical scribe that captures patient conversations and generates clinical notes, as well as coding support and note personalization for clinicians. It serves the healthcare industry, focusing on specialty care and value-based care. It was founded in 2017 and is based in San Francisco, California.
Augmedix is a company that specializes in ambient AI solutions for medical documentation. The company provides services to capture and convert clinician-patient conversations into structured medical notes. Augmedix serves the healthcare sector, collaborating with hospitals and health systems to improve clinical workflows and data management. It was founded in 2012 and is based in San Francisco, California.
Beam Health focuses on healthcare technology, providing AI-based solutions for medical documentation. Its main product, Shine AI, automates the clinical documentation process by listening to consultations, transcribing them, and generating clinical notes that integrate with electronic medical records (EMR) systems. Its offerings are targeted at healthcare providers. It was founded in 2020 and is based in Red Bank, New Jersey.
Loading...